Literature DB >> 3156272

Mechanisms of complement activation by crystalline cholesterol.

W Vogt, I von Zabern, B Damerau, D Hesse, B Lühmann, R Nolte.   

Abstract

The mechanism by which cholesterol crystals activate complement in human serum has been studied. Crystals treated with serum and washed with buffer contain a fixed C3/C5 convertase. Its generation is dependent on the presence of divalent cations (and of factor B). The cholesterol-fixed convertase is subject to decay and can be regenerated by factors B and D. C2 in combination with C1 is not essential but enhances the convertase formation. These findings indicate that it is predominantly the alternative C3/C5 convertase C3bBb(P) that assembles on cholesterol during exposure to human serum. By the use of different antisera and immunofluorescence a C3 fragment, probably C3b, was demonstrated on serum-treated crystals. Its fixation is resistant to washing with urea, and with buffers of differing pH: by hydroxylaminolysis the C3 fragment dissociates from the crystals. This indicates a covalent ester bond linking the labile binding site of activated C3 to the hydroxyl group of cholesterol. Cholesterol acetate does not fix C3 nor acquire a C3-cleaving activity upon contact with serum. In addition, cholesterol crystals bind factor I (C3b inactivator) and in this way may facilitate fixation and amplification of the alternative C3/C5 convertase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156272     DOI: 10.1016/s0161-5890(85)80003-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

Review 1.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

2.  Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue Factor.

Authors:  Caroline S Gravastrand; Bjørg Steinkjer; Bente Halvorsen; Anne Landsem; Mona Skjelland; Eva Astrid Jacobsen; Trent M Woodruff; John D Lambris; Tom E Mollnes; Ole-Lars Brekke; Terje Espevik; Anne Mari A Rokstad
Journal:  J Immunol       Date:  2019-07-03       Impact factor: 5.422

Review 3.  Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.

Authors:  Alicia J Jenkins; Maria B Grant; Julia V Busik
Journal:  Diabetologia       Date:  2022-02-11       Impact factor: 10.460

Review 4.  Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-08-25

5.  Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.

Authors:  Eivind O Samstad; Nathalie Niyonzima; Stig Nymo; Marie H Aune; Liv Ryan; Siril S Bakke; Knut T Lappegård; Ole-Lars Brekke; John D Lambris; Jan K Damås; Eicke Latz; Tom E Mollnes; Terje Espevik
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

6.  Antibodies to cholesterol.

Authors:  G M Swartz; M K Gentry; L M Amende; E J Blanchette-Mackie; C R Alving
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Studies on the immunological properties of oxysterols: in vivo actions of 7,25-dihydroxycholesterol upon murine peritoneal cells.

Authors:  C Moog; Y H Ji; C Waltzinger; B Luu; P Bischoff
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

8.  Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.

Authors:  P S Seifert; F Hugo; J Tranum-Jensen; U Zâhringer; M Muhly; S Bhakdi
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

Review 9.  Why AMD is a disease of ageing and not of development: mechanisms and insights.

Authors:  Kaushal Sharma; Neel Kamal Sharma; Akshay Anand
Journal:  Front Aging Neurosci       Date:  2014-07-10       Impact factor: 5.750

10.  C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques.

Authors:  Katrine Pilely; Stefano Fumagalli; Anne Rosbjerg; Ninette Genster; Mikkel-Ole Skjoedt; Carlo Perego; Angela M R Ferrante; Maria-Grazia De Simoni; Peter Garred
Journal:  Front Immunol       Date:  2017-08-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.